-
Nepal flood survivors return to ruins to salvage memories
-
Venezuela says retains 'sovereignty' in US oil deal
-
Killing of Palestinian children and teens by Israel surges in West Bank
-
NASA's Roman telescope set to launch on cosmic mapping mission
-
Educators keep 9/11 memory alive for next generation, 25 years on
-
Data center backlash scrambles US midterm politics
-
Venezuelans view US oil deal with doubt, hope
-
Emotional Federer inducted into tennis Hall of Fame
-
Gobena and Jepchirchir power to Sydney Marathon victories
-
Hovland takes solo lead as McIlroy surges at Tour Championship
-
Iceland in suspense after close EU vote
-
Djokovic 'prepared' for US Open bid for history
-
Wallabies hold on for victory in Argentina
-
Atletico down Sevilla to go top of La Liga
-
Juve notch second straight win, Fiorentina's centenary party falls flat
-
US deports right-wing provocateur Milo Yiannopoulos
-
Rybakina eases injury fears ahead of US Open
-
Niger junta says it is back in control after soldiers' mutiny
-
Djokovic kicks off latest Grand Slam quest under US Open lights
-
Erasmus calls Rennie barbs over Springbok scrumming 'nonsense'
-
'Sorry' De Zerbi won't panic after Spurs shambles
-
Lawrence's fifty leaves Pakistan facing record chase to level England series
-
UN, Nepal warn of climate threat after deadly floods
-
Netanyahu condemns settler attack in flashpoint West Bank village
-
USTA boss says structure of new player council not yet set
-
Munoz saves Iraola in Liverpool draw, big-spending Spurs lose again
-
Tiny Elversberg stun Leverkusen on Bundesliga debut, Dortmund beat Hamburg
-
Newcastle condemn dismal Spurs to second successive defeat
-
BMC rejects negligence claims in three Rajawadi Hospital maternity cases
-
Five college football games that could shape the 2026 season
-
Editorial questions Letitia James’ record as New York attorney general
-
New finds strengthen case for Bethsaida at Sea of Galilee site
-
Los Angeles triplets weigh 19.3 pounds in unusually heavy birth
-
Felony assaults on older New Yorkers rise sharply, police data show
-
Matt Leinart assesses Arch Manning and the leading names in college football
-
Three Texas Tech softball players hurt in jet ski collision
-
Rural Tamil Nadu students present 64 technology projects at IIT-M research park
-
Tambaram civic groups seek action on eight long-pending issues
-
Tamil Nadu goalball team’s national silver highlights need for wider support
-
Chennai councillors unite across parties to demand ward development funds
-
Tamil Nadu and NUS agree to expand postgraduate and research links
-
Court orders JIPMER assessment of Durai Dayanidhi before money-laundering trial
-
India and China have not named two new border meeting sites
-
Family searches for Boston engineer missing after Nepal-Tibet floods
-
Ankle ligament tear ends Neeraj Chopra’s 2026 season
-
Dolly Parton’s Imagination Library leaves global children’s reading legacy
-
Thirty-seven Mumbai pilgrims return after Nepal flood disruption
-
Police appeal for footage after life-threatening Stratford assault
-
French campaign sharpens as far right accuses left over civil disobedience calls
-
James Cleverly leaves shadow cabinet to seek London mayoralty
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.
ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.
"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."
Solving the $1 million per study problem
While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.
This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.
Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.
The results are compelling:
Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.
$141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.
51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.
Shaping the Future of Study Operations
Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.
Site Identification & Feasibility
Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.
Study Startup
AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.
Remote Monitoring
AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.
Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.
Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.
All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025
Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/
About Florence Healthcare
Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.
Contact Information
Seema Sheth-Voss
[email protected]
(888) 829-0896
SOURCE: Florence Healthcare
View the original press release on ACCESS Newswire
A.Moore--AT